• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自大消化链球菌的L蛋白与κ轻链可变区结合。

Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain.

作者信息

Nilson B H, Solomon A, Björck L, Akerström B

机构信息

Department of Medical and Physiological Chemistry, University of Lund, Sweden.

出版信息

J Biol Chem. 1992 Feb 5;267(4):2234-9.

PMID:1733930
Abstract

Protein L is an immunoglobulin light chain-binding protein expressed by some strains of the anaerobic bacterial species Peptostreptococcus magnus. The major variable region subgroups of human kappa and lambda light chains were tested for protein L binding; V kappa I, V kappa III, and V kappa IV bound protein L, whereas no binding occurred with proteins of the V kappa II subgroup or with any lambda light chain subgroups. Studies of the protein L binding capacity of naturally occurring VL fragments, and VL- and CL-related trypsin- and pepsin-derived peptides prepared from a kappa I light chain, localized the site of interaction to the VL domain. The affinity constant for the binding to an isolated V kappa I fragment was comparable to that for the native protein (Ka 0.9 x 10(9) M-1 and Ka 1.5 x 10(9) M-1, respectively). No binding occurred with CL-related fragments. Extensive reduction and alkylation of the V kappa fragment or the native kappa chain resulted in complete loss of protein L binding. Although it is possible, from comparative amino acid sequence data, to identify certain VL-framework region residues that account for the selective binding of protein L by kappa I, kappa III, and kappa IV proteins, our studies indicate that this interaction is essentially dependent upon the tertiary structural integrity of the kappa chain VL domain.

摘要

蛋白L是一种由某些厌氧细菌大消化链球菌菌株表达的免疫球蛋白轻链结合蛋白。对人κ和λ轻链的主要可变区亚组进行了蛋白L结合测试;VκI、VκIII和VκIV与蛋白L结合,而VκII亚组的蛋白或任何λ轻链亚组均未发生结合。对天然存在的VL片段以及从κI轻链制备的与VL和CL相关的胰蛋白酶和胃蛋白酶衍生肽的蛋白L结合能力进行的研究,将相互作用位点定位到VL结构域。与分离的VκI片段结合的亲和常数与天然蛋白相当(分别为Ka 0.9×10⁹ M⁻¹和Ka 1.5×10⁹ M⁻¹)。与CL相关的片段未发生结合。Vκ片段或天然κ链的广泛还原和烷基化导致蛋白L结合完全丧失。尽管从比较氨基酸序列数据中有可能识别出某些VL框架区残基,这些残基解释了κI、κIII和κIV蛋白对蛋白L的选择性结合,但我们的研究表明,这种相互作用基本上取决于κ链VL结构域的三级结构完整性。

相似文献

1
Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain.来自大消化链球菌的L蛋白与κ轻链可变区结合。
J Biol Chem. 1992 Feb 5;267(4):2234-9.
2
Cloning, expression and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus.基于大消化链球菌蛋白L的κ链结合蛋白Ppl-1的克隆、表达及纯化
Bioseparation. 1995;5(6):359-67.
3
Mapping of the immunoglobulin light chain-binding site of protein L.蛋白质L免疫球蛋白轻链结合位点的定位
J Mol Biol. 1995 Jul 7;250(2):128-33. doi: 10.1006/jmbi.1995.0364.
4
Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins.巨大消化链球菌蛋白L与人抗体之间的复合物揭示了Fab结合蛋白相互作用模式中的结构趋同。
Structure. 2001 Aug;9(8):679-87. doi: 10.1016/s0969-2126(01)00630-x.
5
NMR analysis of the interaction between protein L and Ig light chains.蛋白质L与免疫球蛋白轻链相互作用的核磁共振分析
J Mol Biol. 1997 Jul 4;270(1):8-13. doi: 10.1006/jmbi.1997.1090.
6
Protein L: an immunoglobulin light chain-binding bacterial protein. Characterization of binding and physicochemical properties.蛋白L:一种免疫球蛋白轻链结合细菌蛋白。结合特性及物理化学性质的表征
J Biol Chem. 1989 Nov 25;264(33):19740-6.
7
Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus and a human kappa light chain.巨大消化链球菌蛋白L的单个免疫球蛋白结合结构域与人κ轻链之间的相互作用
Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):193-9.
8
Crystallization and X-ray analysis of a single fab binding domain from protein L of Peptostreptococcus magnus.巨大消化链球菌蛋白L单个Fab结合结构域的结晶及X射线分析。
Proteins. 1995 Dec;23(4):610-2. doi: 10.1002/prot.340230420.
9
Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling.蛋白质PAB,一种嵌合的白蛋白结合细菌蛋白,代表了模块改组的首个当代实例。
J Biol Chem. 1994 Apr 22;269(16):12147-51.
10
Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chains.蛋白质L的单个免疫球蛋白结合结构域与两个当量人κ轻链之间相互作用的观察与表征
J Biol Chem. 2004 Mar 5;279(10):9370-8. doi: 10.1074/jbc.M312938200. Epub 2003 Dec 10.

引用本文的文献

1
Calcium chloride and arginine show diametrically opposite effects on antibody elution in Protein A and Protein L chromatography.氯化钙和精氨酸在蛋白A和蛋白L色谱法中对抗体洗脱表现出截然相反的作用。
J Biol Methods. 2024 Jul 10;11(2):e99010016. doi: 10.14440/jbm.2024.0006. eCollection 2024.
2
Immunomodulating Enzymes from -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs.来自……的免疫调节酶在发病机制中的作用、作为生物技术工具以及作为生物药物。 (注:原文“from -In”表述似乎有误,推测可能是“from...”,这里按推测后的内容翻译,若实际不是这样,请根据正确原文调整)
Microorganisms. 2024 Jan 18;12(1):200. doi: 10.3390/microorganisms12010200.
3
Towards a pan marsupial sero-immunological tool in the demanding field of wildlife serology: Marsupial immunoglobulin-binding capability with protein A/G, protein L and anti-kangaroo antibody.
在野生动物血清学这个极具挑战性的领域中,建立一种通用有袋类血清学免疫工具:蛋白 A/G、蛋白 L 和抗袋鼠抗体与有袋类免疫球蛋白的结合能力。
PLoS One. 2023 Dec 14;18(12):e0295820. doi: 10.1371/journal.pone.0295820. eCollection 2023.
4
Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20.通过打破免疫球蛋白 G 的镜像对称性并同时结合 CD55 和 CD20,有效清除利妥昔单抗耐药的肿瘤细胞。
Sci Rep. 2023 Oct 25;13(1):18275. doi: 10.1038/s41598-023-45491-8.
5
Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™.利用 ALTHEA Gold Plus 文库™发现和优化针对 SARS-CoV-2 的中和抗体。
Int J Mol Sci. 2023 Feb 27;24(5):4609. doi: 10.3390/ijms24054609.
6
More Than Meets the Kappa for Antibody Superantigen Protein L (PpL).抗体超抗原蛋白L(PpL)的κ链结合远超预期。
Antibodies (Basel). 2022 Feb 11;11(1):14. doi: 10.3390/antib11010014.
7
Mass Spectrometry-Based Methods for Immunoglobulin G N-Glycosylation Analysis.基于质谱的免疫球蛋白 G N-糖基化分析方法。
Exp Suppl. 2021;112:73-135. doi: 10.1007/978-3-030-76912-3_3.
8
Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.超抗原识别与相互作用:功能、机制与应用。
Front Immunol. 2021 Sep 20;12:731845. doi: 10.3389/fimmu.2021.731845. eCollection 2021.
9
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.嵌合抗原受体自然杀伤 (CAR-NK) 细胞设计与工程在癌症治疗中的应用。
J Hematol Oncol. 2021 May 1;14(1):73. doi: 10.1186/s13045-021-01083-5.
10
Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles.用于治疗、诊断和研究目的的抗体人源化中的睿智:抗体元件及其作用的考量
Antib Ther. 2020 Apr 18;3(2):71-79. doi: 10.1093/abt/tbaa005. eCollection 2020 Apr.